<p>随着全球市场密切关注经济指标和中央银行的决策，亚洲股市正在应对一个复杂的环境，既有机遇也有挑战。在这种环境中，识别那些交易价格低于其内在价值的股票，对于希望在该地区抓住潜在增长机会的投资者来说，可以是一种战略性的方法。</p>
<h3>基于现金流的亚洲十大被低估股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估算）</strong></td>
<td><strong>折扣（估算）</strong></td>
</tr>
<tr>
<td>西安诺瓦星科技（SZSE:301589）</td>
<td>CN¥154.22</td>
<td>CN¥302.65</td>
<td>49%</td>
</tr>
<tr>
<td>厦门特宝生物（SHSE:688278）</td>
<td>CN¥83.18</td>
<td>CN¥161.78</td>
<td>48.6%</td>
</tr>
<tr>
<td>新龙新材料（SZSE:301565）</td>
<td>CN¥28.14</td>
<td>CN¥55.48</td>
<td>49.3%</td>
</tr>
<tr>
<td>美图（SEHK:1357）</td>
<td>HK$7.47</td>
<td>HK$14.60</td>
<td>48.8%</td>
</tr>
<tr>
<td>最后一公里有限公司（TSE:9252）</td>
<td>¥3530.00</td>
<td>¥6867.62</td>
<td>48.6%</td>
</tr>
<tr>
<td>JUSUNG ENGINEERING 有限公司（KOSDAQ:A036930）</td>
<td>₩29250.00</td>
<td>₩56972.54</td>
<td>48.7%</td>
</tr>
<tr>
<td>东买控股（SEHK:1797）</td>
<td>HK$20.44</td>
<td>HK$40.26</td>
<td>49.2%</td>
</tr>
<tr>
<td>COVER（TSE:5253）</td>
<td>¥1562.00</td>
<td>¥3094.02</td>
<td>49.5%</td>
</tr>
<tr>
<td>中国如意控股（SEHK:136）</td>
<td>HK$2.41</td>
<td>HK$4.80</td>
<td>49.8%</td>
</tr>
<tr>
<td>北京北摩高科技摩擦材料有限公司（SZSE:002985）</td>
<td>CN¥28.28</td>
<td>CN¥55.83</td>
<td>49.3%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们基于现金流的 277 只被低估亚洲股票的完整列表。</p>
<p>在这里，我们突出了一部分我们偏好的股票。</p>
<h2>宁波三星医疗电气有限公司（SHSE:601567）</h2>
<p><strong>概述：</strong> 宁波三星医疗电气有限公司在中国及国际市场上制造和销售电力配电产品，市值为 325.2 亿人民币。</p>
<p><strong>运营：</strong> 宁波三星医疗电气有限公司通过制造和销售电力配电产品在国内外产生收入。</p>
<p><strong>公允价值折扣估算：</strong> 26%</p>
<p>宁波三星医疗电气有限公司的交易价格为 23.14 元，显著低于其估算的公允价值 31.29 元，表明其可能被低估。尽管近期波动较大，但预计该股票的收益在未来三年将以 28.81% 的年率增长，超过中国市场整体 27.2% 的增长率。然而，其 4.19% 的股息收益率并未得到当前收益或自由现金流的良好覆盖，这对寻求收入稳定的投资者构成潜在风险。</p>
<ul>
<li>我们的收益增长报告揭示了宁波三星医疗电气有限公司未来业绩显著增长的潜力。</li>
<li>通过阅读我们的健康报告，深入了解宁波三星医疗电气有限公司的资产负债表。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2ee373e6-53d5-4c83-90e5-36fd85262791/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2ee373e6-53d5-4c83-90e5-36fd85262791/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SHSE:601567 截至 2025 年 12 月的折现现金流</p>
<h2>南亚新材料科技有限公司（SHSE:688519）</h2>
<p><strong>概述：</strong> 南亚新材料科技有限公司专注于复合材料的制造、设计、开发和销售，市值为 159.1 亿人民币。</p>
<p><strong>运营：</strong> 该公司通过其核心活动制造、设计、开发和销售复合材料来产生收入。</p>
<p><strong>公允价值折扣估算：</strong> 15.7%</p>
<p>南亚新材料科技有限公司的交易价格为 69.5 元，低于其估算的公允价值 82.48 元，表明其可能被低估。该公司报告称，2025 年前九个月的收入显著增长至 36.6 亿人民币，净收入从去年同期的 158.1 百万人民币上升。尽管股价波动较大且预计的股本回报率较低，但预计未来三年收益将显著快于市场平均水平。</p>
<ul>
<li>我们最近的增长报告提供了南亚新材料科技有限公司商业前景的良好预测。</li>
<li>点击探索我们在南亚新材料科技有限公司资产负债表健康报告中的详细发现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1a885788-1638-4b9b-a3c1-7d0dc71239fc/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1a885788-1638-4b9b-a3c1-7d0dc71239fc/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SHSE:688519 截至 2025 年 12 月的折现现金流</p>
<h2>MonotaRO（TSE:3064）</h2>
<p><strong>概述：</strong> MonotaRO 有限公司经营一个面向日本及国际工厂的 MRO 产品在线商店，市值为 1.11 万亿日元。</p>
<p><strong>运营：</strong> 该公司的收入主要来自其为工厂提供的间接材料销售业务，收入为 3180.1 亿日元。</p>
<p><strong>公允价值折扣估算：</strong> 16.6%</p>
<p>MonotaRO 的交易价格为 2230 日元，低于其估算的公允价值 2674.47 日元。最近的销售数据显示，2025 年 10 月的销售额达到 294.2 亿日元，而去年同期为 253.5 亿日元。预计收益将以 13.5% 的年率增长，超过日本市场的平均 8.3%，同时收入增长也预计将超过市场水平。然而，该股票近期经历了较高的波动，并且基于现金流的公允价值仅略低。</p>
<ul>
<li>我们精心准备的 MonotaRO 增长报告暗示其未来财务前景可能强于近期业绩。</li>
<li>点击这里访问我们的完整资产负债表健康报告，以了解 MonotaRO 的动态。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a1d4284-1ab3-4c96-923b-30e029bae475/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a1d4284-1ab3-4c96-923b-30e029bae475/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TSE:3064 截至 2025 年 12 月的折现现金流</p>
<h2>关键要点</h2>
<ul>
<li>点击此链接深入了解我们基于现金流的 277 家公司被低估的亚洲股票筛选器。</li>
<li>已经拥有这些公司？将您的投资组合链接到 Simply Wall St，并获取有关您股票的新警告信号的提醒。</li>
<li>使用 Simply Wall St 应用程序提升您的投资能力，享受免费访问涵盖每个大洲的市场情报。</li>
</ul>
<h2>想探索一些替代方案吗？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过稳健的分红支付者来多样化您的投资组合，以提供可靠的收入来源，以应对潜在的市场动荡。</li>
<li>充实您的投资组合，选择那些显示出强劲增长潜力的公司，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不构成财务建议。它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

三星医疗

诺瓦星云

特宝生物

<p>亚洲股票的内在价值估计低至 26%，为投资者提供了增长机会。关键的被低估股票包括西安诺瓦星云、厦门特宝生物和宁波三星医疗电气等。尽管市场波动，这些股票显示出显著的盈利增长潜力。文章强调了在复杂市场环境中识别被低估股票的重要性，并提供了对其财务健康状况和增长预测的见解</p>

<p>As global markets closely monitor economic indicators and central bank decisions, Asian stock markets are navigating a complex landscape marked by both opportunities and challenges. Amidst this environment, identifying stocks that are trading below their intrinsic value can be a strategic approach for investors looking to capitalize on potential growth opportunities in the region.</p>
<div class="lb-trans"><p>随着全球市场密切关注经济指标和中央银行的决策，亚洲股市正在应对一个复杂的环境，既有机遇也有挑战。在这种环境中，识别那些交易价格低于其内在价值的股票，对于希望在该地区抓住潜在增长机会的投资者来说，可以是一种战略性的方法。</p>
</div><h3>Top 10 Undervalued Stocks Based On Cash Flows In Asia</h3>
<div class="lb-trans"><h3>基于现金流的亚洲十大被低估股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Current Price</strong></td>
<td><strong>Fair Value (Est)</strong></td>
<td><strong>Discount (Est)</strong></td>
</tr>
<tr>
<td>Xi'an NovaStar Tech (SZSE:301589)</td>
<td>CN¥154.22</td>
<td>CN¥302.65</td>
<td>49%</td>
</tr>
<tr>
<td>Xiamen Amoytop Biotech (SHSE:688278)</td>
<td>CN¥83.18</td>
<td>CN¥161.78</td>
<td>48.6%</td>
</tr>
<tr>
<td>Sinolong New Materials (SZSE:301565)</td>
<td>CN¥28.14</td>
<td>CN¥55.48</td>
<td>49.3%</td>
</tr>
<tr>
<td>Meitu (SEHK:1357)</td>
<td>HK$7.47</td>
<td>HK$14.60</td>
<td>48.8%</td>
</tr>
<tr>
<td>Last One MileLtd (TSE:9252)</td>
<td>¥3530.00</td>
<td>¥6867.62</td>
<td>48.6%</td>
</tr>
<tr>
<td>JUSUNG ENGINEERINGLtd (KOSDAQ:A036930)</td>
<td>₩29250.00</td>
<td>₩56972.54</td>
<td>48.7%</td>
</tr>
<tr>
<td>East Buy Holding (SEHK:1797)</td>
<td>HK$20.44</td>
<td>HK$40.26</td>
<td>49.2%</td>
</tr>
<tr>
<td>COVER (TSE:5253)</td>
<td>¥1562.00</td>
<td>¥3094.02</td>
<td>49.5%</td>
</tr>
<tr>
<td>China Ruyi Holdings (SEHK:136)</td>
<td>HK$2.41</td>
<td>HK$4.80</td>
<td>49.8%</td>
</tr>
<tr>
<td>Beijing Beimo High-tech Frictional MaterialLtd (SZSE:002985)</td>
<td>CN¥28.28</td>
<td>CN¥55.83</td>
<td>49.3%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估算）</strong></td>
<td><strong>折扣（估算）</strong></td>
</tr>
<tr>
<td>西安诺瓦星科技（SZSE:301589）</td>
<td>CN¥154.22</td>
<td>CN¥302.65</td>
<td>49%</td>
</tr>
<tr>
<td>厦门特宝生物（SHSE:688278）</td>
<td>CN¥83.18</td>
<td>CN¥161.78</td>
<td>48.6%</td>
</tr>
<tr>
<td>新龙新材料（SZSE:301565）</td>
<td>CN¥28.14</td>
<td>CN¥55.48</td>
<td>49.3%</td>
</tr>
<tr>
<td>美图（SEHK:1357）</td>
<td>HK$7.47</td>
<td>HK$14.60</td>
<td>48.8%</td>
</tr>
<tr>
<td>最后一公里有限公司（TSE:9252）</td>
<td>¥3530.00</td>
<td>¥6867.62</td>
<td>48.6%</td>
</tr>
<tr>
<td>JUSUNG ENGINEERING 有限公司（KOSDAQ:A036930）</td>
<td>₩29250.00</td>
<td>₩56972.54</td>
<td>48.7%</td>
</tr>
<tr>
<td>东买控股（SEHK:1797）</td>
<td>HK$20.44</td>
<td>HK$40.26</td>
<td>49.2%</td>
</tr>
<tr>
<td>COVER（TSE:5253）</td>
<td>¥1562.00</td>
<td>¥3094.02</td>
<td>49.5%</td>
</tr>
<tr>
<td>中国如意控股（SEHK:136）</td>
<td>HK$2.41</td>
<td>HK$4.80</td>
<td>49.8%</td>
</tr>
<tr>
<td>北京北摩高科技摩擦材料有限公司（SZSE:002985）</td>
<td>CN¥28.28</td>
<td>CN¥55.83</td>
<td>49.3%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 277 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.</p>
<div class="lb-trans"><p>点击这里查看我们基于现金流的 277 只被低估亚洲股票的完整列表。</p>
</div><p>Here we highlight a subset of our preferred stocks from the screener.</p>
<div class="lb-trans"><p>在这里，我们突出了一部分我们偏好的股票。</p>
</div><h2>Ningbo Sanxing Medical ElectricLtd (SHSE:601567)</h2>
<div class="lb-trans"><h2>宁波三星医疗电气有限公司（SHSE:601567）</h2>
</div><p><strong>Overview:</strong> Ningbo Sanxing Medical Electric Co., Ltd. manufactures and sells power distribution products in China and internationally, with a market cap of CN¥32.52 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 宁波三星医疗电气有限公司在中国及国际市场上制造和销售电力配电产品，市值为 325.2 亿人民币。</p>
</div><p><strong>Operations:</strong> Ningbo Sanxing Medical Electric Co., Ltd. generates revenue by manufacturing and selling power distribution products both domestically and internationally.</p>
<div class="lb-trans"><p><strong>运营：</strong> 宁波三星医疗电气有限公司通过制造和销售电力配电产品在国内外产生收入。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 26%</p>
<div class="lb-trans"><p><strong>公允价值折扣估算：</strong> 26%</p>
</div><p>Ningbo Sanxing Medical Electric Ltd. is trading at CN¥23.14, significantly below its estimated fair value of CN¥31.29, indicating it may be undervalued based on cash flows. Despite recent volatility, the stock's earnings are forecast to grow 28.81% annually over the next three years, outpacing the broader Chinese market's growth rate of 27.2%. However, its dividend yield of 4.19% is not well covered by current earnings or free cash flows, presenting a potential risk for investors seeking income stability.</p>
<div class="lb-trans"><p>宁波三星医疗电气有限公司的交易价格为 23.14 元，显著低于其估算的公允价值 31.29 元，表明其可能被低估。尽管近期波动较大，但预计该股票的收益在未来三年将以 28.81% 的年率增长，超过中国市场整体 27.2% 的增长率。然而，其 4.19% 的股息收益率并未得到当前收益或自由现金流的良好覆盖，这对寻求收入稳定的投资者构成潜在风险。</p>
</div><ul>
<li>Our earnings growth report unveils the potential for significant increases in Ningbo Sanxing Medical ElectricLtd's future results.</li>
<li>Get an in-depth perspective on Ningbo Sanxing Medical ElectricLtd's balance sheet by reading our health report here.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们的收益增长报告揭示了宁波三星医疗电气有限公司未来业绩显著增长的潜力。</li>
<li>通过阅读我们的健康报告，深入了解宁波三星医疗电气有限公司的资产负债表。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2ee373e6-53d5-4c83-90e5-36fd85262791/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/2ee373e6-53d5-4c83-90e5-36fd85262791/chart/dcf?theme=light"/></p>
<p>SHSE:601567 Discounted Cash Flow as at Dec 2025</p>
<div class="lb-trans"><p>SHSE:601567 截至 2025 年 12 月的折现现金流</p>
</div><h2>Nanya New Material TechnologyLtd (SHSE:688519)</h2>
<div class="lb-trans"><h2>南亚新材料科技有限公司（SHSE:688519）</h2>
</div><p><strong>Overview:</strong> Nanya New Material Technology Co., Ltd specializes in the manufacturing, design, development, and sale of composite materials with a market cap of CN¥15.91 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 南亚新材料科技有限公司专注于复合材料的制造、设计、开发和销售，市值为 159.1 亿人民币。</p>
</div><p><strong>Operations:</strong> The company generates revenue through its core activities of manufacturing, designing, developing, and selling composite materials.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司通过其核心活动制造、设计、开发和销售复合材料来产生收入。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 15.7%</p>
<div class="lb-trans"><p><strong>公允价值折扣估算：</strong> 15.7%</p>
</div><p>Nanya New Material Technology Ltd. is trading at CN¥69.5, below its estimated fair value of CN¥82.48, suggesting potential undervaluation based on cash flows. The company reported significant revenue growth to CN¥3.66 billion for the first nine months of 2025, with net income rising to CN¥158.1 million from the previous year’s figures. Despite a volatile share price and low forecasted return on equity, earnings are expected to grow significantly faster than the market average over the next three years.</p>
<div class="lb-trans"><p>南亚新材料科技有限公司的交易价格为 69.5 元，低于其估算的公允价值 82.48 元，表明其可能被低估。该公司报告称，2025 年前九个月的收入显著增长至 36.6 亿人民币，净收入从去年同期的 158.1 百万人民币上升。尽管股价波动较大且预计的股本回报率较低，但预计未来三年收益将显著快于市场平均水平。</p>
</div><ul>
<li>Insights from our recent growth report point to a promising forecast for Nanya New Material TechnologyLtd's business outlook.</li>
<li>Click to explore a detailed breakdown of our findings in Nanya New Material TechnologyLtd's balance sheet health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们最近的增长报告提供了南亚新材料科技有限公司商业前景的良好预测。</li>
<li>点击探索我们在南亚新材料科技有限公司资产负债表健康报告中的详细发现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1a885788-1638-4b9b-a3c1-7d0dc71239fc/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/1a885788-1638-4b9b-a3c1-7d0dc71239fc/chart/dcf?theme=light"/></p>
<p>SHSE:688519 Discounted Cash Flow as at Dec 2025</p>
<div class="lb-trans"><p>SHSE:688519 截至 2025 年 12 月的折现现金流</p>
</div><h2>MonotaRO (TSE:3064)</h2>
<div class="lb-trans"><h2>MonotaRO（TSE:3064）</h2>
</div><p><strong>Overview:</strong> MonotaRO Co., Ltd. operates an online store for MRO products catering to factories both in Japan and internationally, with a market cap of ¥1.11 trillion.</p>
<div class="lb-trans"><p><strong>概述：</strong> MonotaRO 有限公司经营一个面向日本及国际工厂的 MRO 产品在线商店，市值为 1.11 万亿日元。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its Indirect Material Sales Business for Factories, generating ¥318.01 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入主要来自其为工厂提供的间接材料销售业务，收入为 3180.1 亿日元。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 16.6%</p>
<div class="lb-trans"><p><strong>公允价值折扣估算：</strong> 16.6%</p>
</div><p>MonotaRO is trading at ¥2,230, below its estimated fair value of ¥2,674.47. Recent sales data shows robust growth with October 2025 sales reaching ¥29.42 billion compared to ¥25.35 billion a year earlier. Earnings are projected to grow at 13.5% annually, outpacing the JP market's average of 8.3%, while revenue growth is expected to exceed market rates as well. However, the stock has experienced high volatility recently and trades only slightly below fair value based on cash flows.</p>
<div class="lb-trans"><p>MonotaRO 的交易价格为 2230 日元，低于其估算的公允价值 2674.47 日元。最近的销售数据显示，2025 年 10 月的销售额达到 294.2 亿日元，而去年同期为 253.5 亿日元。预计收益将以 13.5% 的年率增长，超过日本市场的平均 8.3%，同时收入增长也预计将超过市场水平。然而，该股票近期经历了较高的波动，并且基于现金流的公允价值仅略低。</p>
</div><ul>
<li>Our expertly prepared growth report on MonotaRO implies its future financial outlook may be stronger than recent results.</li>
<li>Click here and access our complete balance sheet health report to understand the dynamics of MonotaRO.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们精心准备的 MonotaRO 增长报告暗示其未来财务前景可能强于近期业绩。</li>
<li>点击这里访问我们的完整资产负债表健康报告，以了解 MonotaRO 的动态。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a1d4284-1ab3-4c96-923b-30e029bae475/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/0a1d4284-1ab3-4c96-923b-30e029bae475/chart/dcf?theme=light"/></p>
<p>TSE:3064 Discounted Cash Flow as at Dec 2025</p>
<div class="lb-trans"><p>TSE:3064 截至 2025 年 12 月的折现现金流</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><ul>
<li>Click this link to deep-dive into the 277 companies within our Undervalued Asian Stocks Based On Cash Flows screener.</li>
<li>Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.</li>
<li>Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击此链接深入了解我们基于现金流的 277 家公司被低估的亚洲股票筛选器。</li>
<li>已经拥有这些公司？将您的投资组合链接到 Simply Wall St，并获取有关您股票的新警告信号的提醒。</li>
<li>使用 Simply Wall St 应用程序提升您的投资能力，享受免费访问涵盖每个大洲的市场情报。</li>
</ul>
</div><h2>Want To Explore Some Alternatives?</h2>
<div class="lb-trans"><h2>想探索一些替代方案吗？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过稳健的分红支付者来多样化您的投资组合，以提供可靠的收入来源，以应对潜在的市场动荡。</li>
<li>充实您的投资组合，选择那些显示出强劲增长潜力的公司，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不构成财务建议。它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

亚洲市场的股票估计低于其内在价值达 26%